1. CesarmanE, ChangY, MoorePS, SaidJW, KnowlesDM (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186–1191.
2. ChangY, CesarmanE, PessinMS, LeeF, CulpepperJ, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865–1869.
3. SoulierJ, GrolletL, OksenhendlerE, CacoubP, Cazals-HatemD, et al. (1995) Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86: 1276–1280.
4. CostaJ, RabsonAS (1983) Generalised Kaposi's sarcoma is not a neoplasm. Lancet 1: 58.
5. Ganem D (2007) Ksarcoma-associated herpesvirus. In: D. M. Knipe PMH, D. R. Griffin, R. A. Lamb, M. A. Marin, B. Roizman, and S. E. Straus, editor. Fields Virology 5th ed. Philadelphia: Lippincott Williams & Wilkins.
6. ChandranB (2010) Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol 84: 2188–2199.
7. AkulaSM, WangFZ, VieiraJ, ChandranB (2001) Human herpesvirus 8 interaction with target cells involves heparan sulfate. Virology 282: 245–255.
8. WangFZ, AkulaSM, PramodNP, ZengL, ChandranB (2001) Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 75: 7517–7527.
9. HahnA, BirkmannA, WiesE, DorerD, MahrK, et al. (2009) Kaposi's sarcoma-associated herpesvirus gH/gL: glycoprotein export and interaction with cellular receptors. J Virol 83: 396–407.
10. NaranattPP, AkulaSM, ZienCA, KrishnanHH, ChandranB (2003) Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol 77: 1524–1539.
11. WangFZ, AkulaSM, Sharma-WaliaN, ZengL, ChandranB (2003) Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J Virol 77: 3131–3147.
12. VeettilMV, SadagopanS, Sharma-WaliaN, WangFZ, RaghuH, et al. (2008) Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection. J Virol 82: 12126–12144.
13. KoyanoS, MarEC, StameyFR, InoueN (2003) Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion. J Gen Virol 84: 1485–1491.
14. ChakrabortyS, VeettilMV, BotteroV, ChandranB (2012) Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection. Proc Natl Acad Sci U S A 109: E1163–1172.
15. BandyopadhyayC, Valiya-VeettilM, DuttaD, ChakrabortyS, ChandranB (2014) CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells. PLoS Pathog 10: e1003941.
16. BotteroV, ChakrabortyS, ChandranB (2013) Reactive oxygen species are induced by Kaposi's sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry. J Virol 87: 1733–1749.
17. DuttaD, ChakrabortyS, BandyopadhyayC, Valiya VeettilM, AnsariMA, et al. (2013) EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination. PLoS Pathog 9: e1003510.
18. KrishnanHH, Sharma-WaliaN, StreblowDN, NaranattPP, ChandranB (2006) Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J Virol 80: 1167–1180.
19. Sharma-WaliaN, NaranattPP, KrishnanHH, ZengL, ChandranB (2004) Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J Virol 78: 4207–4223.
20. Valiya VeettilM, SadagopanS, KerurN, ChakrabortyS, ChandranB (2010) Interaction of c-Cbl with myosin IIA regulates Bleb associated macropinocytosis of Kaposi's sarcoma-associated herpesvirus. PLoS Pathog 6: e1001238.
21. VeettilMV, Sharma-WaliaN, SadagopanS, RaghuH, SivakumarR, et al. (2006) RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner. J Virol 80: 11432–11446.
22. BotteroV, KerurN, SadagopanS, PatelK, Sharma-WaliaN, et al. (2011) Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Virol 85: 1980–1993.
23. SadagopanS, Sharma-WaliaN, VeettilMV, RaghuH, SivakumarR, et al. (2007) Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J Virol 81: 3949–3968.
24. Sharma-WaliaN, KrishnanHH, NaranattPP, ZengL, SmithMS, et al. (2005) ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 79: 10308–10329.
25. Sharma-WaliaN, RaghuH, SadagopanS, SivakumarR, VeettilMV, et al. (2006) Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J Virol 80: 6534–6552.
26. KrishnanHH, NaranattPP, SmithMS, ZengL, BloomerC, et al. (2004) Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78: 3601–3620.
27. LiX, FengJ, SunR (2011) Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol 85: 715–724.
28. YeF, GaoSJ (2011) A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation. Cell Cycle 10: 3237–3238.
29. YeF, ZhouF, BedollaRG, JonesT, LeiX, et al. (2011) Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency. PLoS Pathog 7: e1002054.
30. MoiP, ChanK, AsunisI, CaoA, KanYW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A 91: 9926–9930.
31. KansanenE, KuosmanenSM, LeinonenH, LevonenAL (2013) The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol 1: 45–49.
32. MitsuishiY, MotohashiH, YamamotoM (2012) The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol 2: 200.
33. TaguchiK, MotohashiH, YamamotoM (2011) Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 16: 123–140.
34. KenslerTW, WakabayashiN, BiswalS (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89–116.
35. ZhangDD, LoSC, CrossJV, TempletonDJ, HanninkM (2004) Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol 24: 10941–10953.
36. ItohK, WakabayashiN, KatohY, IshiiT, IgarashiK, et al. (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13: 76–86.
37. KatohY, ItohK, YoshidaE, MiyagishiM, FukamizuA, et al. (2001) Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6: 857–868.
38. NioiP, NguyenT, SherrattPJ, PickettCB (2005) The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol Cell Biol 25: 10895–10906.
39. JainAK, BloomDA, JaiswalAK (2005) Nuclear import and export signals in control of Nrf2. J Biol Chem 280: 29158–29168.
40. ChowdhryS, ZhangY, McMahonM, SutherlandC, CuadradoA, et al. (2013) Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 32: 3765–3781.
41. HayesJD, FlanaganJU, JowseyIR (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51–88.
42. MoinovaHR, MulcahyRT (1999) Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun 261: 661–668.
43. PresteraT, TalalayP, AlamJ, AhnYI, LeePJ, et al. (1995) Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med 1: 827–837.
44. PrimianoT, KenslerTW, KuppusamyP, ZweierJL, SutterTR (1996) Induction of hepatic heme oxygenase-1 and ferritin in rats by cancer chemopreventive dithiolethiones. Carcinogenesis 17: 2291–2296.
45. ThimmulappaRK, MaiKH, SrisumaS, KenslerTW, YamamotoM, et al. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62: 5196–5203.
46. HayashiA, SuzukiH, ItohK, YamamotoM, SugiyamaY (2003) Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 310: 824–829.
47. MaherJM, DieterMZ, AleksunesLM, SlittAL, GuoG, et al. (2007) Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46: 1597–1610.
48. HirotsuY, KatsuokaF, FunayamaR, NagashimaT, NishidaY, et al. (2012) Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks. Nucleic Acids Res 40: 10228–10239.
49. MitsuishiY, TaguchiK, KawataniY, ShibataT, NukiwaT, et al. (2012) Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66–79.
50. NitureSK, JaiswalAK (2012) Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem 287: 9873–9886.
51. NitureSK, JaiswalAK (2013) Nrf2-induced antiapoptotic Bcl-xL protein enhances cell survival and drug resistance. Free Radic Biol Med 57: 119–131.
52. KimTH, HurEG, KangSJ, KimJA, ThapaD, et al. (2011) NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res 71: 2260–2275.
53. ZhangZ, WangQ, MaJ, YiX, ZhuY, et al. (2013) Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1alpha signaling in human epithelial ovarian cancer. Oncol Rep 29: 1429–1434.
54. ZhouS, YeW, ZhangM, LiangJ (2012) The effects of nrf2 on tumor angiogenesis: a review of the possible mechanisms of action. Crit Rev Eukaryot Gene Expr 22: 149–160.
55. PanH, WangH, ZhuL, MaoL, QiaoL, et al. (2013) The role of Nrf2 in migration and invasion of human glioma cell U251. World Neurosurg 80: 363–370.
56. NguyenT, NioiP, PickettCB (2009) The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 284: 13291–13295.
57. CullinanSB, GordanJD, JinJ, HarperJW, DiehlJA (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: 8477–8486.
58. KobayashiA, KangMI, OkawaH, OhtsujiM, ZenkeY, et al. (2004) Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 24: 7130–7139.
59. ZhangDD (2006) Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38: 769–789.
60. ZhangDD, HanninkM (2003) Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol 23: 8137–8151.
61. BairdL, LleresD, SwiftS, Dinkova-KostovaAT (2013) Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex. Proc Natl Acad Sci U S A 110: 15259–15264.
62. BairdL, SwiftS, LleresD, Dinkova-KostovaAT (2014) Monitoring Keap1-Nrf2 interactions in single live cells. Biotechnol Adv
63. FurukawaM, XiongY (2005) BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol 25: 162–171.
64. McMahonM, ItohK, YamamotoM, HayesJD (2003) Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem 278: 21592–21600.
65. Dinkova-KostovaAT, HoltzclawWD, ColeRN, ItohK, WakabayashiN, et al. (2002) Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99: 11908–11913.
66. NitureSK, KhatriR, JaiswalAK (2014) Regulation of Nrf2-an update. Free Radic Biol Med 66: 36–44.
67. HuangHC, NguyenT, PickettCB (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769–42774.
68. LeeJM, HansonJM, ChuWA, JohnsonJA (2001) Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J Biol Chem 276: 20011–20016.
69. MengX, SunG, YeJ, XuH, WangH, et al. (2014) Notoginsenoside R1-mediated neuroprotection involves estrogen receptor-dependent crosstalk between Akt and ERK1/2 pathways: a novel mechanism of Nrf2/ARE signaling activation. Free Radic Res 48: 445–460.
70. MengXB, SunGB, WangM, SunJ, QinM, et al. (2013) P90RSK and Nrf2 Activation via MEK1/2-ERK1/2 Pathways Mediated by Notoginsenoside R2 to Prevent 6-Hydroxydopamine-Induced Apoptotic Death in SH-SY5Y Cells. Evid Based Complement Alternat Med 2013: 971712.
71. NakasoK, YanoH, FukuharaY, TakeshimaT, Wada-IsoeK, et al. (2003) PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546: 181–184.
72. NumazawaS, IshikawaM, YoshidaA, TanakaS, YoshidaT (2003) Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 285: C334–342.
73. KesicMJ, SimmonsSO, BauerR, JaspersI (2011) Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells. Free Radic Biol Med 51: 444–453.
74. KosmiderB, MessierEM, JanssenWJ, NahreiniP, WangJ, et al. (2012) Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respir Res 13: 43.
75. YagetaY, IshiiY, MorishimaY, MasukoH, AnoS, et al. (2011) Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice. J Virol 85: 4679–4690.
76. LeeJ, KohK, KimYE, AhnJH, KimS (2013) Upregulation of Nrf2 expression by human cytomegalovirus infection protects host cells from oxidative stress. J Gen Virol 94: 1658–1668.
77. BurdetteD, OlivarezM, WarisG (2010) Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J Gen Virol 91: 681–690.
78. DayoubR, VogelA, SchuettJ, LupkeM, SpiekerSM, et al. (2013) Nrf2 activates augmenter of liver regeneration (ALR) via antioxidant response element and links oxidative stress to liver regeneration. Mol Med 19: 237–244.
79. IvanovAV, SmirnovaOA, IvanovaON, MasalovaOV, KochetkovSN, et al. (2011) Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS One 6: e24957.
80. LeeJC, TsengCK, YoungKC, SunHY, WangSW, et al. (2014) Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. Br J Pharmacol 171: 237–252.
81. EdwardsMR, JohnsonB, MireCE, XuW, ShabmanRS, et al. (2014) The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway. Cell Rep 6: 1017–1025.
82. PageA, VolchkovaVA, ReidSP, MateoM, Bagnaud-BauleA, et al. (2014) Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. Cell Rep 6: 1026–1036.
83. MallerySR, PeiP, LandwehrDJ, ClarkCM, BradburnJE, et al. (2004) Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis 25: 597–603.
84. PaulAG, ChandranB, Sharma-WaliaN (2013) Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies. Transl Res 162: 77–92.
85. PaulAG, ChandranB, Sharma-WaliaN (2013) Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines. Transl Res 161: 447–468.
86. KwakMK, ItohK, YamamotoM, KenslerTW (2002) Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 22: 2883–2892.
87. MaQ, HeX (2012) Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev 64: 1055–1081.
88. HayakawaM, MiyashitaH, SakamotoI, KitagawaM, TanakaH, et al. (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 3356–3366.
89. StuehrDJ, FasehunOA, KwonNS, GrossSS, GonzalezJA, et al. (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98–103.
90. LeeOH, JainAK, PapushaV, JaiswalAK (2007) An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem 282: 36412–36420.
91. FarahCA, SossinWS (2012) The role of C2 domains in PKC signaling. Adv Exp Med Biol 740: 663–683.
92. NewtonAC (1995) Protein kinase C: structure, function, and regulation. J Biol Chem 270: 28495–28498.
93. WebbBL, HirstSJ, GiembyczMA (2000) Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis. Br J Pharmacol 130: 1433–1452.
94. BalaK, BoscoR, GramolelliS, HaasDA, KatiS, et al. (2012) Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog 8: e1002927.
95. SadagopanS, Valiya VeettilM, PaudelN, BotteroV, ChandranB (2011) Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. J Virol 85: 2666–2685.
96. SmitMJ, VerzijlD, CasarosaP, NavisM, TimmermanH, et al. (2002) Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol 76: 1744–1752.
97. PaulAG, Sharma-WaliaN, ChandranB (2011) Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma. PLoS One 6: e24379.
98. AokiY, TosatoG (2001) Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas. Leuk Lymphoma 41: 229–237.
99. DaiL, BratoevaM, TooleBP, QinZ, ParsonsC (2012) KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Int J Cancer 131: 834–843.
100. GasperiniP, SakakibaraS, TosatoG (2008) Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis. J Leukoc Biol 84: 994–1000.
101. HamdenKE, WhitmanAG, FordPW, SheltonJG, McCubreyJA, et al. (2005) Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors. Leukemia 19: 18–26.
102. HaywardGS (2003) Initiation of angiogenic Kaposi's sarcoma lesions. Cancer Cell 3: 1–3.
103. NishiJ, MaruyamaI (2000) Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node. Leuk Lymphoma 38: 387–394.
104. SivakumarR, Sharma-WaliaN, RaghuH, VeettilMV, SadagopanS, et al. (2008) Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J Virol 82: 1759–1776.
105. LiuD, JiL, WangY, ZhengL (2012) Cyclooxygenase-2 expression, prostacyclin production and endothelial protection of high-density lipoprotein. Cardiovasc Hematol Disord Drug Targets 12: 98–105.
106. George PaulA, Sharma-WaliaN, KerurN, WhiteC, ChandranB (2010) Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen. Cancer Res 70: 3697–3708.
107. ShelbyBD, LaMarcaHL, McFerrinHE, NelsonAB, LaskyJA, et al. (2007) Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells. Virol J 4: 87.
108. Sharma-WaliaN, George PaulA, PatelK, ChandranK, AhmadW, et al. (2010) NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2). J Virol 84: 12733–12753.
109. Sharma-WaliaN, PatelK, ChandranK, MargineanA, BotteroV, et al. (2012) COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP. Oncogenesis 1: e5.
110. ArltA, SebensS, KrebsS, GeismannC, GrossmannM, et al. (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32: 4825–4835.
111. KobayashiA, KangMI, WataiY, TongKI, ShibataT, et al. (2006) Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26: 221–229.
112. FujimuroM, LiuJ, ZhuJ, YokosawaH, HaywardSD (2005) Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen. J Virol 79: 10429–10441.
113. NaranattPP, KrishnanHH, SvojanovskySR, BloomerC, MathurS, et al. (2004) Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res 64: 72–84.
114. MarquezRT, XuL (2012) Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch. Am J Cancer Res 2: 214–221.
115. Sharma-WaliaN, PaulAG, BotteroV, SadagopanS, VeettilMV, et al. (2010) Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog 6: e1000777.
116. AkulaSM, PramodNP, WangFZ, ChandranB (2002) Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108: 407–419.
117. VartRJ, NikitenkoLL, LagosD, TrotterMW, CannonM, et al. (2007) Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res 67: 4042–4051.